Dr Cristina Smolenschi

Spécialité

Oncologue médical, expert estomac, colon, foie et pancréas

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

• Real-world efficacy of zanidatamab in patients with HER2 positive advanced biliary tract cancers. (3 juin 2025)
• Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials. (16 mai 2025)
• A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer. (1 avr. 2025)
• Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC Registry. (1 avr. 2025)
• Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. (1 mars 2025)